Diabetic Cardiomyopathy
Chromium shortens QTc interval duration in type 2 diabetic patients
Published in Diabetes Week, July 4th, 2005
"We investigated the potential effects of chromium supplementation on QTc interval duration in type 2 diabetic patients. Of 60 patients with type 2 diabetes mellitus, 30 were randomly assigned to group A, and 30 to group B. Group A received 1000 mcg of chromium picolinate (CrPic) daily for 3 months, followed by placebo in the next 3 months; group B was treated with placebo for the first 3 months and CrPic in the next 3 months. At each visit, QT interval was measured on a standard electrocardiogram by averaging three consecutive beats in leads II and V4 and corrected for heart rate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2005-07-04)
More Articles from Diabetes Week
- Diabetes Pathogenesis
Features of type 1 diabetes at onset in Swedish children described - Diabetes Prevention
Evidence reported of ability to manipulate beta cell autoimmunity in infants - Diabetes Prevention
Single session of exercise enhances insulin sensitivity for 24 hours - Endocrinology
IRE-Bp1 may be the transcriptional mediator of insulin's metabolic action - Adipose Tissue
Adipocytes have a metabolic role in inflammation - Adipose Tissue
Altered adipokine levels linked with inflammatory conditions - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
